Autoimmune responses and inflammation in type 2 diabetes
- PMID: 32202348
- DOI: 10.1002/JLB.3MR0220-243R
Autoimmune responses and inflammation in type 2 diabetes
Abstract
Obesity-induced insulin resistance is one of the largest noncommunicable disease epidemics that we are facing at the moment. Changes in lifestyle and greater availability of low nutritional value, high caloric food has led to the highest rates of obesity in history. Obesity impacts the immune system and obesity-associated inflammation contributes to metabolic diseases, such as type 2 diabetes. Both the adaptive and the innate immune system play a role in the regulation of glycemic control, and there is a need to understand how metabolic imbalances drive disease pathogenesis. This review discusses the cell types, mediators, and pathways that contribute to immunologic-metabolic crosstalk and explores how the immune system might be targeted as a strategy to treat metabolic disease.
Keywords: adipose tissue; autoimmunity; inflammation; obesity.
©2020 Society for Leukocyte Biology.
References
REFERENCES
-
- Magliano DJ, Zimmet P, Shaw JE. Classification of diabetes mellitus and other categories of glucose intolerance. International Textbook of Diabetes Mellitus. Chichester, UK: John Wiley & Sons, Ltd; 2015:1-16.
-
- You W-P, Henneberg M. Type 1 diabetes prevalence increasing globally and regionally: the role of natural selection and life expectancy at birth. BMJ Open Diabet Res Care. 2016;4(1):e000161.
-
- Katsarou A, Gudbjörnsdottir S, Rawshani A, et al. Type 1 diabetes mellitus. Nat Rev Dis Primers. 2017;3:1-18.
-
- Després J-P, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881-887.
-
- Evans JMM, Newton RW, Ruta DA, MacDonald TM, Morris AD. Socio-economic status, obesity and prevalence of type 1 and type 2 diabetes mellitus. Diabet Med. 2000;17(6):478-480.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
